文献速递重症综合管理与镇静镇痛消化、代谢与肾脏急症

前脑啡肽与常规方法评估脓毒症危重患者肾功能的比较

Proenkephalin Compared to Conventional Methods to Assess Kidney Function in Critically Ill Sepsis Patients.
PubMed 文献 · Shock · 2020-01-01
一句话结论在非稳态脓毒症危重患者中,血浆前脑啡肽浓度比基于肌酐的方法更准确地反映真实肾小球滤过率。

该先导研究纳入23例脓毒症休克危重患者,在6小时窗口内以碘海醇血浆清除率作为真实肾小球滤过率金标准,比较血浆前脑啡肽浓度与基于肌酐的估算肾小球滤过率(MDRD公式)及内生肌酐清除率的准确性。结果显示,估算肾小球滤过率与碘海醇清除率相关(R=0.82,P<0.0001),但偏差和变异性较大:估算肾小球滤过率平均高估真实肾小球滤过率31±35%(95%一致性界限-37%至100%),内生肌酐清除率平均高估37±49%(95%一致性界限-59%至133%)。血浆前脑啡肽与碘海醇清除率呈非常强的负相关(R=0.90,P<0.0001),其相关性有优于估算肾小球滤过率(P=0.06)和内生肌酐清除率(P=0.08)的趋势。作者认为,在非稳态危重患者中,血浆前脑啡肽可能是有前景的肾功能评估生物标志物。

要点

  • 在23例脓毒症休克非稳态危重患者中,血浆前脑啡肽与碘海醇血浆清除率呈非常强负相关(R=0.90,P<0.0001)。
  • 基于肌酐的估算肾小球滤过率(MDRD公式)平均高估真实肾小球滤过率31±35%(95%一致性界限-37%至100%)。
  • 内生肌酐清除率平均高估真实肾小球滤过率37±49%(95%一致性界限-59%至133%)。
  • 血浆前脑啡肽与碘海醇清除率的相关性有优于估算肾小球滤过率(P=0.06)和内生肌酐清除率(P=0.08)的趋势。
  • 作者认为血浆前脑啡肽可能是在非稳态条件下准确且可行的肾功能评估生物标志物。

适用人群与场景

  • 23例脓毒症休克危重患者,处于非稳态状态。

研究设计与关键结果

  • 先导研究纳入23例脓毒症休克危重患者,在6小时窗口内以碘海醇血浆清除率(GFRiohexol)为真实肾小球滤过率金标准。
  • 估算肾小球滤过率(eGFRMDRD)与GFRiohexol相关(R=0.82,P<0.0001),但平均高估真实肾小球滤过率31±35%(95%一致性界限-37%至100%)。
  • 内生肌酐清除率(GFRECC)与GFRiohexol相关(R=0.82,P<0.0001),但平均高估真实肾小球滤过率37±49%(95%一致性界限-59%至133%)。
  • 血浆前脑啡肽浓度与GFRiohexol呈非常强负相关(R=0.90,P<0.0001),其相关性有优于eGFRMDRD(P=0.06)和GFRECC(P=0.08)的趋势。

证据类型、等级与局限

  • 证据类型:先导研究。
  • 局限:原文未报告局限性。

对床旁实践的改变

  • 作者认为,在非稳态脓毒症危重患者中,血浆前脑啡肽浓度比基于肌酐的常规方法更准确地反映真实肾小球滤过率,可能是有前景的肾功能评估生物标志物。

提炼说明

  • 本条依据论文摘要整理;摘要未涉及「诊断标准与关键阈值」「处置流程与药物剂量」「红旗征与不能漏的情况」「指南或共识出处」,故未列出这些栏目;全文请点「阅读原文」。
英文原文(摘要)· 点击展开

BACKGROUND: The assessment of renal function in clinical practice remains challenging. Using creatinine to assess the glomerular filtration rate (GFR) is notoriously inaccurate, and determination of the true GFR, e.g., using inulin or iohexol, is laborious and not feasible in daily practice. Proenkephalin (PENK) is a novel candidate biomarker for kidney function that is filtrated in the glomerulus, has shown to represent steady-state GFR in patients with different severities of renal insufficiency. In this pilot study in non-steady-state critically ill patients, we compared plasma PENK concentrations with creatinine-based GFR assessments and validated both against the "true GFR" measured using a gold standard method: iohexol plasma clearance.

METHODS: Twenty-three critically ill patients with septic shock were included. Kidney function was determined using the Modification of Diet in Renal Disease formula (eGFRMDRD), Endogenous Creatinine Clearance (GFRECC), and iohexol plasma clearance (GFRiohexol) during a 6-h window. Plasma PENK concentrations were measured using the penKid immunoassay.

RESULTS: The eGFRMDRD and GFRECC correlated with the GFRiohexol (R = 0.82, P < 0.0001 and R = 0.82, P < 0.0001 respectively); however, bias and variability were considerable: the eGFRMDRD overestimated the true GFR with 31 ± 35% (95% limits of agreement: -37% to 100%) and the GFRECC with 37 ± 49% (95% limits of agreement: -59% to 133%). Plasma PENK concentrations showed a very strong inverse correlation with the GFRiohexol (R = 0.90, P < 0.0001) which tended to be better compared with the correlation of eGFRMDRD (P = 0.06) and GFRECC (P = 0.08) with the GFRiohexol.

CONCLUSIONS: In this pilot study in non-steady-state critically ill sepsis patients, GFR appears to be more accurately reflected by plasma PENK concentrations compared to conventional creatinine-based methods. Therefore, PENK holds promise as an accurate and feasible biomarker to determine kidney function during non-steady-state conditions in the critically ill.

来源:Shock,查看原文。版权归原作者所有。

参考来源

  1. Beunders R, van Groenendael R, Leijte GP, et al. Proenkephalin Compared to Conventional Methods to Assess Kidney Function in Critically Ill Sepsis Patients. Shock. 2020. PMID: 31977957. doi:10.1097/SHK.0000000000001510

供执业医师抢救与诊疗参考,不替代临床判断;剂量请结合体重、肝肾功能和本院药品规格复核,以指南原文为准。